<!DOCTYPE html>
<html><head><style>table, th, td {border: 1px solid black;border-collapse: collapse;}</style></head>
<table colsep="0" frame="topbot" id="tbl0005" trsep="0" xmlns="http://www.elsevier.com/xml/common/cals/dtd">
<label>
        Table 1
       </label>
<caption id="cap0010">
<simple-para id="spar0010" view="all">
         Purification chart of bevacizumab using Ac-PHQGQHIGVSK-agarose matrix.
        </simple-para>
</caption>

<tgroup cols="6">
<colspec colname="col1"/>
<colspec colname="col2"/>
<colspec colname="col3"/>
<colspec colname="col4"/>
<colspec colname="col5"/>
<colspec colname="col6"/>
<thead valign="top">
<tr trsep="1">
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Sample
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">

           Total protein (mg)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">

           Total bevacizumab (mg)
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">

           Purity %
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Fold purification
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           Yield
           <br/>
           (%)
          </td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">

           Crude sample
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0.487
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0.219
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           45.0
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           1.0
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           100
          </td>
</tr>
<tr>
<td align="left" role="trhead" xmlns="http://www.elsevier.com/xml/common/dtd">
           Eluate fraction
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0.210
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           0.206
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           98.1
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           2.2
          </td>
<td align="left" xmlns="http://www.elsevier.com/xml/common/dtd">
           94.1
          </td>
</tr>
</tbody>
</tgroup>
<table-footnote id="tblfn0005">

<note-para id="npar0005" view="all">
         Bevacizumab-producing CHO cell culture filtrate from mAbxience SAU.
        </note-para>
</table-footnote>
<table-footnote id="tblfn0010">

<note-para id="npar0010" view="all">
         Protein concentration determined by Bradford reagent.
        </note-para>
</table-footnote>
<table-footnote id="tblfn0015">

<note-para id="npar0015" view="all">
         Bevacizumab concentration was determined by HPLC with a protein A column.
        </note-para>
</table-footnote>
<table-footnote id="tblfn0020">

<note-para id="npar0020" view="all">
         Purity defined as amount of bevacizumab as a fraction of total amount of protein.
        </note-para>
</table-footnote>
</table>
</html>